RayThera Inc.
Tracked across 1 events · 10 articles · First seen Jun 17, 2026 · Last active Jun 18, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: RayThera Inc. is being acquired by Biogen for up to $1 billion, allowing its small-molecule therapies for immunology to advance into clinical development with Biogen's global capabilities.
Jun 17, 2026 · 10 articles
ERGEN INTELLIGENCE
Track RayThera Inc. live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard